Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Gene therapy to develop a genetically engineered cardiac pacemaker.

Christopher M Glenn¹, Steven M Pogwizd

¹Department of Medicine, University of Illinois at Chicago, Chicago, Ill 60612, USA.

The Journal of Cardiovascular Nursing

|December 19, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reductive stress induces unresolved ER stress and proteotoxic cardiomyopathy.

Redox biology·2025

Same author

CD206<sup>+</sup>IL-4Rα<sup>+</sup> Macrophages Are Drivers of Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.

Circulation·2025

Same author

Trials and tribulations of cell therapy for heart failure: an update on ongoing trials.

Nature reviews. Cardiology·2024

Same author

Serine-threonine protein phosphatase regulation of Cx43 dephosphorylation in arrhythmogenic disorders.

Cellular signalling·2021

Same author

Identification of Nrf2-responsive microRNA networks as putative mediators of myocardial reductive stress.

Scientific reports·2021

Same author

Molecular remodeling of Cx43, but not structural remodeling, promotes arrhythmias in an arrhythmogenic canine model of nonischemic heart failure.

Journal of molecular and cellular cardiology·2021

Same journal

Predictors of Prolonged Intensive Care Unit Stay After Heart Valve Surgery: A Case-Control Study.

The Journal of cardiovascular nursing·2026

Same journal

Characteristics and Care Practices in People Hospitalized for Heart Failure With Coexisting Diabetes: A Single-Center Retrospective Observational Study.

The Journal of cardiovascular nursing·2026

Same journal

Association of a Diet Index for the Gut Microbiome With Hypertension and Obesity-Related Hypertension: A Cross-Sectional Analysis of NHANES 2007-2020.

The Journal of cardiovascular nursing·2026

Same journal

Device-Assessed Physical Activity and Cardiometabolic Health in Chinese American Women With a History of Gestational Diabetes Mellitus.

The Journal of cardiovascular nursing·2026

Same journal

Physical Frailty, Self-Care Behaviors, and 6-Month Clinical Outcomes Among Adults With Heart Failure.

The Journal of cardiovascular nursing·2026

Same journal

Challenges Experienced by Patients With Chronic Venous Disease in Unresolved Postoperative Recovery After Iliac Vein Stenting: A Phenomenological Study.

The Journal of cardiovascular nursing·2026

See all related articles

Genetic engineering successfully created biological pacemakers by modifying ventricular myocytes. This gene therapy approach offers a promising alternative to traditional pacemakers for treating heart rhythm disorders.

Area of Science:

Biotechnology
Cardiovascular Research
Gene Therapy

Background:

Traditional cardiac pacemakers for bradydysrhythmias have limitations, including life-threatening complications and high costs.
Ventricular myocytes have a more negative diastolic potential than pacemaker cells due to the inward rectifying potassium current (IK1), which pacemaker cells lack.

Purpose of the Study:

To investigate the potential of genetic engineering to create a biological pacemaker.
To explore the feasibility of converting ventricular myocytes into pacemaker cells using gene transfer.

Main Methods:

Isolated the Kir2.1 gene responsible for IK1.
Mutated the Kir2.1 gene to create a dominant-negative, non-functional channel.
Utilized adenoviral vectors for gene delivery to the hearts of guinea pigs.

Related Experiment Videos

Main Results:

Successfully converted some ventricular myocytes into functional pacemaker cells.
Demonstrated proof of principle for gene transfer in treating electrophysiological disorders.
Established a novel biological pacemaker approach.

Conclusions:

Gene transfer holds significant therapeutic promise for treating cardiac conduction system diseases.
This biological pacemaker approach could offer an alternative to traditional electronic pacemakers.
Further research is needed to establish long-term safety and efficacy.